Corporate news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine Grünwald, September 10, 2020 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded...
Ad hoc news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE Grünwald, September 10, 2020 – Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) and BioNTech SE, Mainz, Germany, have agreed that their production...
Corporate News back to archive Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic Group revenue up 14% year-on-year to EUR 378 million Adjusted EBITDA of EUR 92 million around 2% above previous year’s level Forecast...
ESG: A topic for each and every company? You think that ESG does not concern you – after all, you are not listed on the stock market? Unfortunately, we have to destroy this illusion: Good ESG reporting is becoming increasingly relevant for non-listed companies...
Corporate news to the archive Expansion of the Management Board of Delticom AG Hanover, September 03, 2020 – The Supervisory Board of Delticom AG (German Securities Code (WKN) 514680, ISIN DE 00005146807, stock market symbol DEX), Europe’s leading online...